Author

E. E. Nakayama

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:protein structure prediction· 1 Approach:statistical model· 1

Frequent Co-Authors

H. Arase· 3 shared T. Shioda· 3 shared C. Ono· 2 shared H. Nakagami· 2 shared S. Torii· 2 shared W. T. Soh· 2 shared Y. Liu· 2 shared Y. Matsuura· 2 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

H. Arase

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivMar 23, 2021

Identification, crystallization and epitope determination of public TCR shared and expanded in COVID-19 patients

X. Lu, Y. Hosono, S. Ishizuka…·S. Yamasaki

The paper identifies and crystallizes public TCRs from SARS-CoV-2-specific Tfh cells in COVID-19 patients, showing they recognize conserved spike epitopes and cross-react with symbiotic bacteria.

DOI 10.1084/jem.20211327

humanproteomics

𝕏 PostBluesky

MicrobiologybioRxivDec 18, 2020

An infectivity-enhancing site on the SARS-CoV-2 spike protein is targeted by COVID-19 patient antibodies

Y. Liu, W. T. Soh, A. Tada…·H. Arase

This study identifies an NTD site on SARS-CoV-2 spike protein that enhances infectivity when targeted by antibodies, and finds these antibodies are present in hospitalized patients and some uninfected donors.

DOI 10.1016/j.cell.2021.05.032

humanproteomics

𝕏 PostBluesky

MicrobiologybioRxivPreprintNov 5, 2020

The N-terminal domain of spike glycoprotein mediates SARS-CoV-2 infection by associating with L-SIGN and DC-SIGN

W. T. Soh, Y. Liu, E. E. Nakayama…·H. Arase

This study identifies L-SIGN and DC-SIGN as receptors for the N-terminal domain of SARS-CoV-2 spike protein, showing their role in infection and the importance of anti-NTD antibodies.

DOI 10.1101/2020.11.05.369264

humanexperimental assay

𝕏 PostBluesky